GL

Gaifa Lai

SC Schering: 5 patents #587 of 2,442Top 25%
PH Pharmacopeia: 4 patents #27 of 211Top 15%
PD Pharmacopeia Drug Discovery: 3 patents #66 of 193Top 35%
Merck: 3 patents #3,073 of 9,382Top 35%
Overall (All Time): #649,908 of 4,157,543Top 20%
8
Patents All Time

Issued Patents All Time

Patent #TitleCo-InventorsDate
8829036 Heterocyclic aspartyl protease inhibitors Zhaoning Zhu, Brian McKittrick, Zhong-Yue Sun, Yuanzan C. Ye, Johannes H. Voight +27 more 2014-09-09
8691833 Heterocyclic aspartyl protease inhibitors Zhaoning Zhu, Brian McKittrick, Zhong-Yue Sun, Yuanzan C. Ye, Johannes H. Voight +27 more 2014-04-08
8691831 Heterocyclic aspartyl protease inhibitors Zhaoning Zhu, Brian McKittrick, Zhong-Yue Sun, Yuanzan C. Ye, Johannes H. Voight +27 more 2014-04-08
7964646 3,4-DI-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands Arthur G. Taveras, Cynthia Aki, Richard Bond, Jianping Chao, Michael P. Dwyer +10 more 2011-06-21
7763609 Heterocyclic aspartyl protease inhibitors Zhaoning Zhu, Brian McKittrick, Zhong-Yue Sun, Yuanzan C. Ye, Johannes H. Voigt +27 more 2010-07-27
7691856 Thiadiazoledioxides and thiadiazoleoxides as CXC- and CC-chemokine receptor ligands Arthur G. Taveras, Jianhua Chao, Purakkattle Biju, Younong Yu, Cynthia Aki +5 more 2010-04-06
7671212 Isothiazole dioxides as CXC- and CC-chemokine receptor ligands Arthur G. Taveras, J. Merritt, John J. Baldwin, Junying Zheng, Purakkattle Biju +3 more 2010-03-02
7132445 3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands Arthur G. Taveras, Cynthia Aki, Richard Bond, Jianping Chao, Michael P. Dwyer +15 more 2006-11-07